Victrex plc (LON:VCT – Get Free Report) shares hit a new 52-week low during trading on Thursday . The stock traded as low as GBX 933 ($12.32) and last traded at GBX 962 ($12.71), with a volume of 161420 shares. The stock had previously closed at GBX 953 ($12.59).
Wall Street Analyst Weigh In
Separately, Berenberg Bank dropped their price target on Victrex from GBX 1,491 ($19.70) to GBX 1,290 ($17.04) and set a “hold” rating on the stock in a research report on Wednesday, August 28th.
View Our Latest Report on Victrex
Victrex Trading Up 0.9 %
Insider Activity
In other Victrex news, insider Jakob Sigurdsson bought 3,000 shares of the business’s stock in a transaction on Friday, July 5th. The shares were purchased at an average price of GBX 1,189 ($15.71) per share, with a total value of £35,670 ($47,120.21). In other news, insider Jakob Sigurdsson acquired 3,000 shares of the business’s stock in a transaction dated Friday, July 5th. The stock was acquired at an average price of GBX 1,189 ($15.71) per share, for a total transaction of £35,670 ($47,120.21). Also, insider Ros Rivaz bought 1,950 shares of the stock in a transaction that occurred on Monday, August 5th. The shares were purchased at an average cost of GBX 1,020 ($13.47) per share, for a total transaction of £19,890 ($26,274.77). Over the last ninety days, insiders purchased 18,053 shares of company stock valued at $19,439,953. 1.65% of the stock is currently owned by insiders.
About Victrex
Victrex plc, through its subsidiaries, engages in the manufacture and sale of polymer solutions worldwide. The company operates through two segments, Sustainable Solutions and Medical. It develops PEEK and PAEK based polymer solutions, and semi-finished and finished parts. The company also provides specialist solutions for medical device manufacturers; sells thermoplastic polymers; sustainable solutions for energy and industrial, VAR, automotive, aerospace, and electronics markets; and engages in trading activities.
See Also
- Five stocks we like better than Victrex
- How to Know if a Stock Pays Dividends and When They Are Paid Out
- Edgewise Therapeutics Soars 50%: Key Reasons Behind the Surge
- 3 Small Caps With Big Return Potential
- How the Fed’s Rate Cut Could Supercharge These 3 ETFs
- With Risk Tolerance, One Size Does Not Fit All
- Microsoft Stock: 3 Reasons It’s Ready to Crush Q4
Receive News & Ratings for Victrex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Victrex and related companies with MarketBeat.com's FREE daily email newsletter.